ClinicalTrials.Veeva

Menu

SPI-directed Analgesia for Lumbar Discectomy

M

Medical University of Silesia

Status

Completed

Conditions

Lumbar Disc Disease

Treatments

Drug: Ropivacaine
Drug: Bupivacaine
Drug: Metamizol
Drug: Tramadol
Other: control group

Study type

Interventional

Funder types

Other

Identifiers

NCT02971540
SilesianMUKOAiIT1

Details and patient eligibility

About

The aim of this randomized trial is to assess the efficacy of analgesia for lumbar discectomy and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively.

Patients received either preemptive local tissue infiltration at surgical site using either 0,2% ropivacaine with fentanyl or 0,2% bupivacaine with fenthanyl or preemptive intravenous infusion using metamizole and tramadol.

Full description

Monitoring depth of anaesthesia using spectral entropy (SE) and quality of neuromuscular block are routine in modern anaesthesia, whereas monitoring of analgesia still requires further studies. Recently, the Surgical Pleth Index (SPI) was added as a surrogate variable showing the nociception-antinociception balance into abovementioned parametres constituting a novel approach in monitoring patients intraoperatively, known as adequacy of anaesthesia (AoA) or tailor-made anaesthesia. This study aims at evaluating utility of SPI-directed analgesia in patients undergoing general anaesthesia (GA) where analgesia intraoperatively will be achieved either with regional preemptive wound infiltration using 0,2 % ropivacaine with fentanyl or 0,2 % bupivacaine with fentanyl or intravenous analgesia using continuous infusion of metamizole with tramadol for lumbar discectomy. Intraoperatively, SPI value will be recorded with sampling frequency of 1 minute. When SPI value reaches a level higher than 15 SPI points above basic level, a rescue dose of 1mg/kg body weight of fentanyl will be administered intravenously every 5 minutes until SPI value decreases to basic level calculated previously before operation started.

Additionally, the investigators will compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) values for monitoring the efficacy of analgesia postoperatively. After emergence from GA patients will be questioned in terms of their pain intensity in a scale 0-10. In the case of pain perception above 3, a bolus of 2mg of morphine will be administered intravenously every 10 minutes until pain perception will be lower than 4. SPI values will be recorded every 1 minute and analysed for aute pain (NRS 7-10), average (4-6) and mild pain perception intervals to assess if there exists a correlation between NRS and SPI.

In addition, some patients develop Failed Back Surgery Syndrome (FBSS) following lumbar surgeries so the investigators will aim to analyze if SPI-directed analgesia intra- and post-operatively reduces rate of FBSS. After 5 months after operation patient will be surveyed using melzack protocol to assess the rate of FBSS as well as symptoms of chronic pain.

Enrollment

132 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • written consent to participate in the study
  • written consent to undergo general anaesthesia with local wound infiltration and surgery of discectomy

Exclusion criteria

  • allergy to local anaesthetics
  • necessity of administration of vasoactive drugs influencing SPI monitoring
  • pregnancy

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

132 participants in 5 patient groups

bupivacaine, LA, solution
Experimental group
Description:
an a local anesthetic administered for local wound infiltration on each side in a single dose of 10 ml of 0,2% solution per segment of vertrebral columne with potential duration time of up to 8 hours according to manufacturers data
Treatment:
Drug: Tramadol
Other: control group
Drug: Metamizol
Drug: Ropivacaine
ropivacaine, LA, solution
Experimental group
Description:
an a local anesthetic administered for local wound infiltration on each side in a single dose of 10 ml of 0,2% solution per segment of vertrebral columne with potential duration time of up to 8 hours according to manufacturers data
Treatment:
Drug: Tramadol
Other: control group
Drug: Metamizol
Drug: Bupivacaine
metamizol, analgesic, solution
Experimental group
Description:
an analgesic drug administered intravenously for pre-emptive analgesia in a initial dose of 1-1,25g with potential duration time of up to 6 hours according to manufacturers data
Treatment:
Other: control group
Drug: Ropivacaine
Drug: Bupivacaine
tramadol, analgesic, solution
Experimental group
Description:
a half-opioid drug administered intravenously for pre-emptive analgesia in a initial dose of 2 mg per kg of body weight with potential duration time of up to 6 hours according to manufacturers data
Treatment:
Drug: Tramadol
Drug: Metamizol
Drug: Ropivacaine
Drug: Bupivacaine
control group
Experimental group
Description:
no pre-emptive analgesia will be used.
Treatment:
Drug: Tramadol
Other: control group
Drug: Metamizol
Drug: Ropivacaine
Drug: Bupivacaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems